RNAi expression constructs

Details RNAi expression constructs RNAi expression constructs

2006-02-03

2011-12-13

Vivlemore, Tracy (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S320100, C514S04400A

Reexamination Certificate

active

08076471

ABSTRACT:
The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.

REFERENCES:
patent: 6218181 (2001-04-01), Verma et al.
patent: 6509323 (2003-01-01), Davis et al.
patent: 6573099 (2003-06-01), Graham
patent: 2002/0162126 (2002-10-01), Beach et al.
patent: 2004/0053876 (2004-03-01), Turner et al.
patent: 2004/0214329 (2004-10-01), Kay et al.
patent: 2004/0220130 (2004-11-01), Robbins et al.
patent: 2005/0008617 (2005-01-01), Chen et al.
patent: 2005/0197313 (2005-09-01), Roelvink et al.
patent: 2006/0128617 (2006-06-01), Kohara et al.
patent: WO 03/022052 (2003-03-01), None
patent: WO 03/070750 (2003-08-01), None
patent: WO 03/078629 (2003-09-01), None
patent: WO 2004/011647 (2004-02-01), None
patent: WO 2004/106517 (2004-12-01), None
patent: WO 2005/087926 (2005-09-01), None
Fire et al., “Potent and Specific Genetic Interference by Double-Stranded RNA inCaenorhabditis Elegans,” Nature, 1998, vol. 391, pp. 806-811.
Tuschl et al., “Targeted mRNA Degradation by Double-Stranded In Vitro,”Genes and Development, 1999, vol. 13, pp. 3191-3197.
Elbashir et al., “Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells.”Nature, 2001, vol. 411, pp. 494-498.
Kurreck, “Antisense Technologies, Improvement Through Novel Chemical Modifications,”European Journal of Biochemistry, 2003, vol. 270, pp. 1628-1644.
Harborth et al., “Sequence, Chemical, and Structural Variation of Small Interfering RNAs and Short Hairpin RNAs and the Effect on Mammalian Gene Silencing,”Antisense and Nucleic Acid Drug Development, 2003, vol. 13, No. 2, pp. 83-105.
Boden et al., “Human Immunodeficiency Virus Type 1 Escape from RNA Interference,”Journal of Virology, 2003, vol. 77, No. 21, pp. 11531-11535.
Gitlin et al., “Poliovirus Escape from RNA Interference: Short Interfering RNA-Target Recognition and Implications for Therapeutic Approaches”Journal of Virology, 2005, vol. 79, No. 2, 1027-1035.
Higashibata et al., “Identification of Promoter Regions Involved in Cell- and Developmental Stage-Specific Osteopontin Expression in Bone, Kidney, Placenta, and Mammary Gland: An Analysis of Transgenic Mice,”Journal of Bone and Mineral Research, 2004, vol. 19, No. 1, pp. 78-88.
Hoggatt et al., “Cell-Specific Regulatory Modules Control Expression of Genes in Vascular and Visceral Smooth Muscle Tissues,”Circulation Research, 2002, vol. 91, pp. 1151-1159.
Sohal et al., “Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein,” Circulation Research, 2001, vol. 89, pp. 20-25.
Zhang et al., “Multiple Variable First Exons: A Mechanism for Cell- and Tissue-Specific Gene Regulation,”Genome Research, 2004, vol. 14, pp. 79-89.
Maraia et al., “The Human Y4 Small Cytoplasmic RNA Gene is Controlled by Upstream Elements and Resides on Chromosome 7 with all other hY scRNA Genes,”Nucleic Acids Research, 1994, vol. 22, No. 15, pp. 3045-3052.
Maraia et al., “Gene Encoding Human Ro-Associated Autoantigen Y5 RNA,”Nucleic Acids Research, 1996, vol. 24, No. 18, pp. 3552-3559.
Xia et al., “An Enhanced U6 Promoter for Synthesis of Short Hairpin RNA”Nucleic Acids Research, 2003, vol. 31, No. 17, pp. e100 (1-5).
Myers et al., “Optimal Alignments in Linear Space,”Computer Applications in the Biosciences, 1988, vol. 4, No. 1, pp. 11-17.
Pearson et al., “Improved Tools for Biological Sequence Comparison ”Proceedings of the National Academy of Science of the United States of America, 1988, vol. 85, pp. 2444-2448.
Karlin et al., “Applications and Statistics for Multiple High-Scoring Segments in Molecular Sequences”,Proceedings of the National Academy of Science, 1993, vol. 90, pp. 5873-5877.
Nakai et al., “A Limited Number of Transducible Hepatocytes Restricts a Wide-Range Linear Vector Dose Response in Recombinant Adeno-Associated Virus-Mediated Liver Transduction,”Journal of Virology, 2002, vol. 76, No. 22, pp. 11343-11349.
Kay et al., “Looking into the Safety of AAV Vectors,”Nature, 2003, vol. 424, p. 251.
Thomas et al., “Progress and Problems with the Use of Viral Vectors for Gene Therapy,”Nature Reviews, Genetics, 2003, vol. 4, pp. 346-358.
Tomar et al., “Use of Adeno-Associated Viral Vector for Delivery of Small Interfering RNA,”Oncogene, 2003, vol. 22, pp. 5712-5715.
De et al., “High Levels of Persistent Expression of αl-Antitrypsin Mediated by the Nonhuman Primate Serotype rh.10 Adeno-Associated Virus Despite Preexisting Immunity to Common Human Adeno-Associated Viruses,”Molecular Therapy, 2006, vol. 13, No. 1, pp. 67-76.
Zhu et al., “Sustained Whole-Body Functional Rescue in Congestive Heart Failure and Muscular Dystrophy Hamsters by Systemic Gene Transfer,”Circulation, 2005, vol. 112, pp. 2650-2659.
Mingozzi et al., “Improved Hepatic Gene Transfer by Using an Adeno-Associated Virus Serotype 5 Vector,”Journal of Virology, 2002, vol. 76, No. 20, pp. 10497-10502.
Thomas et al., “Rapid Uncoating of Vector Genomes is the Key to Efficient Liver Transduction with Pseudotyped Adeno-Associated Virus Vectors,”Journal of Virology, 2004, vol. 78, No. 6, pp. 3110-3122.
Grimm et al., “Preclinical In Vivo Evaluation of Pseudotyped Adeno-Associated Virus Vectors for Liver Gene Therapy,”Blood, 2003, vol. 102, No. 7, pp. 2412-2419.
Wang et al., “Rapid and Highly Efficient Transduction by Double-Stranded Adeno-Associated Virus Vectors In Vitro and In Vivo”Gene Therapy, 2003, vol. 10, pp. 2105-2111.
Nakai et al., “Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice,”Journal of Virology, 2005, vol. 79, No. 1, pp. 214-224.
Grimm et al., “Liver Transduction with Recombinant Adeno-Associated Virus is Primarily Restricted by Capsid Serotype Not Vector Genotype,”Journal of Virology, 2006, vol. 80, No. 1, pp. 426-439.
Yant et al., “Transposition from a Gutless Adeno-Transposon Vector Stabilizes Transgene Expression in Vivo,”Nature Biotechnology, 2002, vol. 20, pp. 999-1004.
Perri et al., “Replicon Vectors Derived from Sindbis Virus and Semliki Forest Virus That Establish Persistent Replication in Host Cells,”Journal of Virology, 2000, vol. 74, No. 20, pp. 9802-9807.
Chen et al., “Minicircle DNA Vectors Devoid of Bacterial DNA Result in Persistent and High-Level Transgene Expression in Vivo,”Molecular Therapy, 2003, vol. 8, No. 3, pp. 495-500.
Furth et al., “Gene Transfer into Somatic Tissues by Jet Injection,”Analytical Biochemistry, 1992, vol. 205, pp. 365-368.
Tang et al., “Genetic Immunization is a Simple Method for Eliciting an Immune Response,”Nature, 1992, vol. 356, pp. 152-154.
Yokota et al., “Inhibition of Intracellular Hepatitis C Virus Replication by Synthetic and Vector-Derived Small Interfering RNAs,”EMBO Reports, 2003, vol. 4, No. 6, pp. 602-608.
Domitrovich et al., “Multiple, Dispersed Human U6 Small Nuclear RNA Genes with Varied Transcriptional Efficiencies,”Nucleic Acids Research, 2003, vol., pp. 2344-2352.
Boden et al., “Promoter Choice Affects the Potency of HIV-1 Specific RNA Interference,”Nucleic Acids Research, 2003, vol. 31, No. 17, pp. 5033-5038.
Kawasaki et al., “Short Hairpin Type of dsRNAs that are Controlled by tRNAValPromoter Significantly Induce RNAi-Mediated Gene Silencing in the Cytoplasm of Human Cells,”Nucleic Acids Research, 2003, vol. 31, No. 2, pp.700-707.
In the U.S. Patent and Trademark Office, Non-Final Office Action in re: U.S. Appl. No. 11/347,028, dated Jun. 16, 2009, 12 pages.
In the U.S. Patent and Trademark Of

Affiliated with

Also associated with

Rating

RNAi expression constructs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with RNAi expression constructs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RNAi expression constructs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4311895